Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, … , Matthew S. Kelly, Genevieve G. Fouda
Carolina Garrido, … , Matthew S. Kelly, Genevieve G. Fouda
Published July 6, 2021
Citation Information: JCI Insight. 2021;6(17):e150909. https://doi.org/10.1172/jci.insight.150909.
View: Text | PDF
Research Article Immunology Infectious disease

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents

  • Text
  • PDF
Abstract

As SARS-CoV-2 continues to spread globally, questions have emerged regarding the strength and durability of immune responses in specific populations. In this study, we evaluated humoral immune responses in 69 children and adolescents with asymptomatic or mild symptomatic SARS-CoV-2 infection. We detected robust IgM, IgG, and IgA antibody responses to a broad array of SARS-CoV-2 antigens at the time of acute infection and 2 and 4 months after acute infection in all participants. Notably, these antibody responses were associated with virus-neutralizing activity that was still detectable 4 months after acute infection in 94% of children. Moreover, antibody responses and neutralizing activity in sera from children and adolescents were comparable or superior to those observed in sera from 24 adults with mild symptomatic infection. Taken together, these findings indicate that children and adolescents with mild or asymptomatic SARS-CoV-2 infection generate robust and durable humoral immune responses that can likely contribute to protection from reinfection.

Authors

Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, Tulika Singh, Eleanor C. Semmes, Debra J. Lugo, Alexandre T. Rotta, Nicholas A. Turner, Thomas W. Burke, Micah T. McClain, Elizabeth A. Petzold, Sallie R. Permar, M. Anthony Moody, Christopher W. Woods, Matthew S. Kelly, Genevieve G. Fouda

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 1 3 10 14 5 33
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (33)

Title and authors Publication Year
Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques
Issah YA, Hu X, Isaac J, Shen X, Davis D, Ozorowski G, Sewall LM, Zhang S, Kang E, Vuong K, Dennis M, Chen JL, Ramos JM, Yasmeen A, Eudailey J, Cupo A, Weinbaum C, Gao H, Stanfield-Oakley S, Ferrari G, Klasse PJ, Fouda G, Hudgens M, Ward AB, Montefiori DC, Sanders RW, Moore JP, Van Rompay KK, De Paris K, Permar SR, Nelson AN
bioRxiv 2025
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.
Sun YK, Wang C, Lin PQ, Hu L, Ye J, Gao ZG, Lin R, Li HM, Shu Q, Huang LS, Tan LH
2024
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection
Piazzesi A, Pane S, Del Chierico F, Romani L, Campana A, Palma P, Putignani L
Frontiers in Cellular and Infection Microbiology 2024
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age
Dalapati T, Williams CA, Giorgi EE, Hurst JH, Herbek S, Chen JL, Kosman C, Rotta AT, Turner NA, Pulido N, Aquino JN, Pfeiffer TS, Rodriguez J, Fouda GG, Permar SR, Kelly MS
Pediatrics 2024
Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies
Buonsenso D, Cusenza F, Passadore L, Bonanno F, De Guido C, Esposito S
Frontiers in immunology 2023
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups
Abdulla ZA, Al-Bashir SM, Alzoubi H, Al-Salih NS, Aldamen AA, Abdulazeez AZ
Pathogens 2023
The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
Vanetti C, Lampasona V, Stracuzzi M, Fenizia C, Biasin M, Saulle I, Limanaqi F, Abdelsalam A, Loretelli C, Paradiso L, Longoni E, Barcellini L, Piemonti L, Marzinotto I, Dispinseri S, Amendola A, Fappani C, Tanzi E, Clerici MS, Scarlatti G, Zuccotti GV, Giacomet V, Trabattoni D
International journal of molecular sciences 2023
Serologic response to COVID-19 infection or vaccination in pediatric kidney transplant recipients compared to healthy children.
Ziv N, Gimelraikh Y, Ashkenazi-Hoffnung L, Alfandary H, Borovitz Y, Dagan A, Levi S, Hamdani G, Levy-Erez D, Landau D, Koren G, Talgam-Horshi E, Haskin O
Transplant Immunology 2023
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity
Benede NS, Tincho MB, Walters A, Subbiah V, Ngomti A, Baguma R, Butters C, Mennen M, Skelem S, Adriaanse M, van Graan S, Balla SR, Moyo-Gwete T, Moore PL, Botha M, Workman L, Zar HJ, Ntusi NA, Zühlke L, Webb K, Riou C, Burgers WA, Keeton RS
2023
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents.
Messiah SE, Talebi Y, Swartz MD, Sabharwal R, Han H, Bergqvist E, Kohl HW 3rd, Valerio-Shewmaker M, DeSantis SM, Yaseen A, Kelder SH, Ross J, Padilla LN, Gonzalez MO, Wu L, Lakey D, Shuford JA, Pont SJ, Boerwinkle E
Pediatric Research 2023
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
Paniskaki K, Goretzki S, Anft M, Konik MJ, Lechtenberg K, Vogl M, Meister TL, Pfaender S, Zettler M, Jäger J, Dolff S, Westhoff TH, Rohn H, Felderhoff-Mueser U, Stervbo U, Witzke O, Dohna-schwake C, Babel N
BMC Infectious Diseases 2023
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Raineri A, Radtke T, Rueegg S, Haile SR, Menges D, Ballouz T, Ulyte A, Fehr J, Cornejo DL, Pantaleo G, Pellaton C, Fenwick C, Puhan MA, Kriemler S
Nature Communications 2023
Differences in the Clinical Manifestations and Host Immune Responses to SARS-CoV-2 Variants in Children Compared to Adults
Demirhan S, Goldman DL, Herold BC
Journal of Clinical Medicine 2023
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity
Benede N, Tincho MB, Walters A, Subbiah V, Ngomti A, Baguma R, Butters C, Hahnle L, Mennen M, Skelem S, Adriaanse M, Facey-Thomas H, Scott C, Day J, Spracklen TF, van Graan S, Balla SR, Moyo-Gwete T, Moore PL, MacGinty R, Botha M, Workman L, Johnson M, Goldblatt D, Zar HJ, Ntusi NA, Zühlke L, Webb K, Riou C, Burgers WA, Keeton RS
iScience 2023
Binding and neutralizing antibody responses to SARS-CoV-2 in young children exceed those in adults
Ruth A. Karron, Maria Garcia Quesada, Elizabeth A. Schappell, Stephen D. Schmidt, Maria Deloria Knoll, Marissa K. Hetrich, Vic Veguilla, Nicole A Doria-Rose, Fatimah S. Dawood
JCI Insight 2022
Immunology of SARS-CoV-2 infection in children
J Chou, P Thomas, A Randolph
Nature Immunology 2022
Comparison of Seroconversion in Children and Adults With Mild COVID-19
Z Toh, J Anderson, N Mazarakis, M Neeland, R Higgins, K Rautenbacher, K Dohle, J Nguyen, I Overmars, C Donato, S Sarkar, V Clifford, A Daley, S Nicholson, F Mordant, K Subbarao, D Burgner, N Curtis, J Bines, S McNab, A Steer, K Mulholland, S Tosif, N Crawford, D Pellicci, L Do, P Licciardi
2022
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
S Pilz, V Theiler-Schwetz, C Trummer, R Krause, J Ioannidis
Environmental Research 2022
Antibody Responses to SARS-CoV-2 in Children With COVID-19
M Han, J Um, E Lee, K Kim, S Chang, H Lee, Y Kim, Y Choi, E Cho, D Kim, J Choi, J Lee, M Kim, K Chung, H Min, Y Choe, D Lim, J Park, E Choi
Journal of the Pediatric Infectious Diseases Society 2022
Beyond GWAS—Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19?
Szyda J, Dobosz P, Stojak J, Sypniewski M, Suchocki T, Kotlarz K, Mroczek M, Stępień M, Słomian D, Butkiewicz S, Sztromwasser P, Liu J, Król ZJ
International journal of molecular sciences 2022
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021
Tunheim G, Rø GØ, Chopra A, Aase A, Kran AB, Vaage JT, Lund\u2010Johansen F, Hungnes O
Influenza and Other Respiratory Viruses 2022
Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia
Isnaini N, Mardian Y, Lokida D, Budiono F, Butar-butar DP, Arlinda D, Salim G, Kosasih H, Wulan WN, Perodin J, Neal A, Lane HC, Karyana M
Frontiers in Medicine 2022
A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
El-Ghitany EM, Farag S, Farghaly AG, Hashish MH, Hassaan MA, Omran EA
Tropical Medicine and Health 2022
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study
Seery V, Raiden S, Russo C, Borda M, Herrera L, Uranga M, Varese A, Marcó del Pont M, Chirino C, Erramuspe C, Álvarez LS, Lenoir M, Morales LD, Davenport C, Alarcón Flores A, Huespe Auchter S, Ruiz Y, Monsalvo L, Sastoque L, Gavazzi M, Mazzitelli I, Di Diego F, Longueira Y, Mazzitelli B, Sananez I, De Carli N, Biglione MM, Gómez Penedo JM, Ceballos A, Laufer N, Ferrero F, Geffner J, Arruvito L
EBioMedicine 2022
Distinct Immune Phenotypes and Cytokine Profiles in Children with Differing Severity of COVID-19
Talarico LB, Toledano A, Contrini MM, Torrado LE, Martínez MP, Gaillard MI, Caratozzolo A, Byrne AB, Bonnin FA, Tineo MS, Yfran EW, Acosta PL, López EL
The Pediatric Infectious Disease Journal 2022
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
Harthaller T, Borena W, Bante D, Schäfer H, Strallhofer O, Zöggeler T, Hochmuth E, Hoch L, Rössler A, von Laer D, Kimpel J, Falkensammer B
Viruses 2022
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection.
Tomasi L, Thiriard A, Heyndrickx L, Georges D, Van den Wijngaert S, Olislagers V, Sharma S, Matagne A, Ackerman ME, Ariën KK, Goetghebuer T, Marchant A
Open Forum Infectious Diseases 2022
Dam-infant rhesus macaque pairs to dissect age-dependent responses to SARS-CoV-2 infection
Langel SN, Garrido C, Phan C, Travieso T, Kirshner H, DeMarco T, Ma ZM, Reader JR, Olstad KJ, Sammak RL, Lakshmanappa YS, Roh JW, Watanabe J, Usachenko J, Immareddy R, Pollard R, Iyer SS, Permar S, Miller LA, Van Rompay KK, Blasi M
ImmunoHorizons 2022
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children
I Sananez, SC Raiden, SC Algieri, M Uranga, NA Grisolía, D Filippo, ND Carli, SD Lalla, H Cairoli, MJ Chiolo, CN Meregalli, E Cohen, G Mosquera, MM del Pont, LI Giménez, G Gregorio, M Sarli, AL Alcalde, C Davenport, MJ Bruera, N Simaz, MF Pérez, V Nivela, C Bayle, L Alvarez, M Revetria, P Tuccillo, MT Agosta, H Pérez, SV Nova, P Suárez, EM Takata, M García, J Lattner, MJ Rolón, P Coll, M Salvatori, C Piccardo, C Russo, A Varese, V Seery, MP Holgado, ML Polo, A Ceballos, M Nuñez, JM Penedo, F Ferrero, J Geffner, L Arruvito
EBioMedicine 2021
Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention
G Blanchard-Rohner, A Didierlaurent, A Tilmanne, P Smeesters, A Marchant
Human vaccines 2021
Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control
A Werzberger, JM Carreño, SS Team, A Polinger, F Krammer, P Zachariah
American journal of infection control 2021
Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
X Tian, W Jiang, H Zhang, , L Li, W Liu, J Li
Frontiers in microbiology 2021
Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population
A Méndez-Echevarría, T Sainz, I Falces-Romero, B de Felipe, L Escolano, S Alcolea, L Pertiñez, O Neth, C Calvo
Pathogens 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts